What is the cure rate for epclusa in patients with genotype 1?

What “cure rate” means for Epclusa (sofosbuvir/velpatasvir)

In hepatitis C treatment, “cure rate” usually refers to the share of patients who achieve sustained virologic response (SVR), meaning the hepatitis C virus is not detected after completing therapy and follow-up. Epclusa’s results are commonly reported as SVR12 rates (undetectable virus 12 weeks after treatment).

SVR/cure rate for Epclusa in genotype 1

The provided information does not include Epclusa genotype 1 cure-rate (SVR) numbers. Because cure rates depend on regimen duration, prior treatment history (treatment-naïve vs. treatment-experienced), and liver status (for example, compensated cirrhosis), SVR12 figures for genotype 1 cannot be stated accurately without the missing trial or labeling data.

How to find the exact genotype 1 cure rate you need

If you tell me whether patients were treatment-naïve or treatment-experienced (and whether cirrhosis was present), I can point you to the correct SVR12/cure-rate figure from the relevant Epclusa study or prescribing information.